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Summary
Microbial pathogens use environmental cues to trigger the developmental events needed to infect
mammalian hosts or transmit to disease-vectors. The parasites causing African sleeping sickness
respond to citrate/cis aconitate (CCA) to initiate life-cycle development when transmitted to their
tsetse-fly vector. This requires hypersensitization of the parasites to CCA by exposure to low
temperature, conditions encountered after tsetse feeding at dusk or dawn. Here we identify a
carboxylate-transporter family, PAD (Proteins Associated with Differentiation) required for
perception of this differentiation signal. Consistent with predictions for the response of
trypanosomes to CCA, PAD proteins are expressed on the surface of the transmission-competent
‘stumpy-form’ parasites in the bloodstream and at least one member is thermoregulated, showing
elevated expression and surface-access at low-temperature. Moreover, RNAi-mediated ablation of
PAD expression diminishes CCA-induced differentiation and eliminates CCA-hypersensitivity
under cold-shock conditions. As well as being molecular transducers of the differentiation signal
in these parasites, PAD proteins provide the first surface-marker able to discriminate the
transmission-stage of trypanosomes in their mammalian host.
Insect-borne parasites undergo life-cycle differentiation to adapt to rapid changes in
temperature1,2, nutritional-availability3 and potential immunological-attack4 as they enter
their arthropod vector. The cues that induce such changes are often well characterised, such
as temperature reduction and pH changes5 or exposure to arthropod-derived factors6.
However, the surface molecules that transmit these signals and initiate intracellular
differentiation events in microbial parasites are often not well characterised.
African trypanosomes are protozoan parasites responsible for fatal disease in humans and
livestock in sub-Saharan Africa, generating significant restrictions in health and welfare in
afflicted regions7. The transmission of these parasites by tsetse flies requires the
development of bloodstream ‘stumpy-forms’, a G0-arrested cell-type pre-adapted for
transmission8-10. Stumpy-forms arise via quorum-sensing from proliferative ‘slender-
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forms’ at the peak of each parasitaemia in response to an unidentified parasite-derived
signalling factor, stumpy induction factor (SIF)11. Although the morphological extremes of
slender and stumpy-forms are easily distinguished, the development from slender- to
stumpy-morphology is progressive12, with transitional forms loosely described as
‘intermediates’. To date, no developmentally-regulated surface marker has been identified
that discriminates slender and stumpy-cells.
When ingested by tsetse during a bloodmeal, slender-forms are killed whereas stumpy-forms
differentiate to procyclic-forms13. Bloodstream trypanosomes can also be induced to
differentiate in vitro by the Krebs-cycle intermediates, citrate or cis-aconitate (CCA)14.
Recently, it was discovered that temperature reduction from 37°C to 20°C could induce
hypersensitivity of stumpy-forms to CCA2, such that differentiation was induced at
concentrations found in the tsetse (15.9μM15) or ingested blood-meal (~130μM16). This
probably represents a natural condition in the trypanosome life-cycle, since tsetse are
exposed to cool conditions when feeding at dusk or early morning2. Nonetheless, the
molecule responsible for the transmission of the CCA differentiation signal has remained
unidentified.
PAD family identification and expression
We previously selected a trypanosome line (DiD1, Defective in Differentiation-1) with
reduced ability to differentiate to procyclic forms10. The expression profile of DiD1 was
compared with its differentiation-competent parent by differential hybridization of labelled
cDNA to genomic arrays. This identified 2 adjacent genes on chromosome 7 of the T.brucei
genome (Tb927.7.5930 and Tb927.7.5940), there being a stronger signal with DiD1-derived
cDNA compared to the parental. These genes comprise the first two genes in an 8-gene
array at the end of a unidirectional gene cluster (named the ‘PAD’ gene array, for ‘Proteins
Associated with Differentiation’; see below) (Supplementary Fig. 1a). Although no mutation
in either gene was detected (Supplementary Fig. 2), northern blotting confirmed the
differential expression of both PAD1 and PAD2 genes in the DiD1 line (Figure 1a). Further,
PAD1 and PAD2 mRNA showed stage-regulated expression, PAD1 being enriched in
stumpy-forms, whereas PAD2 was elevated in procyclic-forms. Neither PAD1 nor PAD2
mRNA was significantly expressed in slender-forms (Figure 1a).
The PAD genes encode closely-related members of a family of 14 transmembrane-spanning
proteins of the major facilitator superfamily (Figure 1b; Supplementary Fig. 1b). PSI-
BLAST searches revealed a conserved domain in plant nodulin-like proteins (PF06813) and
closest overall similarity to carboxylate transporters. Supporting this, Xenopus oocytes
microinjected with cRNA encoding either PAD1 or PAD2 showed a marked increase in the
uptake of 14C citrate relative to non-injected controls (Figure 1c).
An antibody detecting all members of the PAD protein family reacted with distinct bands in
different trypanosome life-cycle stages (Figure 1d); although there was no significant
expression in slender-forms, stumpy-forms exhibited two prominent bands at 55kDal and
57kDal, whereas procyclic-forms predominantly expressed the 57kDal band. Neither
corresponded to the predicted size of any PAD protein, probably because proteins with
extensive transmembrane regions frequently migrate aberrantly. Specific anti-peptide
antibodies showed that the 55kDal and 57kDal bands corresponded to PAD1 and PAD2
respectively, and that PAD1 was stumpy-form specific, whereas PAD2 was expressed 6-fold
more in procyclic-forms than stumpy-forms (Figure 1d). During synchronous differentiation
from stumpy- to procyclic-forms, PAD1 was retained only during the first 24h, whereas
PAD2 was strongly induced during this period (up to 17-fold at 24h; Supplementary Fig. 3).
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PAD1 marks the transmissible stumpy form
The PAD1 expression profile suggested that it might provide a useful cytological marker for
stumpy-forms. To investigate this, the location and expression of PAD1 was analysed in
mixed populations of slender and stumpy-forms. Figure 2a (left two panels) shows
immunofluorescence images demonstrating stumpy-specific expression of PAD1. Confocal
images (Figure 2a, right panel) demonstrated an intense staining at the stumpy-cell
periphery, revealing surface membrane labelling. To quantitate the stumpy-specific
expression of PAD1, ‘intermediate’ cell populations were assayed with PAD1 and
counterstained with DAPI, allowing their cell-cycle position to be determined. In
trypanosomes, cells in G1/G0 and S-phase have 1 kinetoplast and 1 nucleus (1K1N),
whereas G2/M and post-mitotic cells have a 2K1N or 2K2N DNA configuration,
respectively17. Since stumpy-forms are uniformly arrested in G1/G018, 2K1N or 2K2N
cells can be unambiguously assigned as slender-forms. Detailed examination of cells within
each category of 1K1N, 2K1N or 2K2N (an overall analysis of >10,000 cells) demonstrated
that dividing-cells and cells with a slender morphology were overwhelmingly negative for
PAD1 (Figure 2b). However, ~10% of 1K1N and 2K2N slender-cells were PAD1-positive:
these may represent ‘intermediate’ cells that have committed to stumpy-formation.
To investigate whether only the PAD1-positive bloodstream trypanosomes were competent
to differentiate to procyclic-forms, mixed populations of slender and stumpy-forms were
examined 6 hours after exposure to cis-aconitate (CA) for EP-procyclin expression, an early
marker for differentiation19. This confirmed a precise correspondence between EP-
procyclin and PAD1 expression, with 96% of cells showing matching staining for both
markers (Figure 2c,d). Thus, PAD1 identifies stumpy-forms in a bloodstream population as
those competent to differentiate to procyclic forms.
PAD2 is thermoregulated
As surface carboxylate transporters expressed on stumpy forms, PAD proteins were good
candidates as transducers of the CCA-developmental signal. To evaluate this, we initially
tested the inducibility of PAD proteins at 20°C, a predicted requirement for physiological
CCA-sensitivity2. This revealed that PAD2 was consistently up-regulated ~4-fold (range
3-32 fold) at 20°C. Analysing two trypanosome strains (T. brucei AnTat 1.1 and T. brucei
EATRO 2340) demonstrated 4-fold and 3.8-fold up-regulation of PAD2, respectively, at
20°C when compared to 37°C (Figure 3a). In contrast, PAD1 expression was unaltered. This
eliminated the possibility that the elevation of PAD2-expression was due to general
enhancement of membrane protein expression at low-temperature. Other stress conditions
such as pH or cell concentration did not affect PAD2 expression (Supplementary Fig. 4 and
data not shown). Interestingly, at 37°C PAD2 was predominantly at the flagellar pocket,
whereas it was surface located at 20°C (Figure 3b, c), this redistribution occurring within 60
min (Supplementary Fig. 5). Thus, PAD2 is a novel example of both a thermoregulated
parasite molecule1 and a transmembrane protein exhibiting regulated surface distribution20.
PAD proteins convey the CCA differentiation signal
To functionally test PAD proteins in CCA-initiated differentiation, a gene fragment with
>95% identity between each PAD gene was targeted by RNAi, enabling simultaneous
knock-down of all members. This was performed in the pleomorphic T. brucei AnTat 90:13
line2 that generates stumpy-forms at high frequency, exhibits cold-sensitivity to CCA and
has been engineered for doxycycline-inducible RNAi-mediated transcript ablation. The
resulting transgenic cell-line, in parallel with the parental line, was grown in mice
±doxycycline induction for 6 days, each producing >80% stumpy populations
(Supplementary Fig. 6). Although the RNAi effect was considerably leaky, there was 80%
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depletion of PAD proteins in the RNAi-induced cells (Figure 4a), demonstrating that
significant PAD expression was not required for either stumpy formation or survival
(Supplementary Fig. 6). Once the transgenic stumpy-forms were harvested from blood and
incubated for 16h at 20°C, they were exposed to different concentrations of CA and
differentiation monitored by EP-procyclin expression. Cells incubated at 20°C exhibited the
expected cold-induction of EP-procyclin expression2 although this was consistently and
inducibly reduced in the RNAi line (Figure 4b, “0h CS” samples). This may indicate some
interaction between PAD and EP-procyclin surface expression similar to mammalian
monocarboxylate transporters, which co-associate with single-pass membrane proteins for
surface access and activity21. Most significantly, however, PAD-depletion reduced the
differentiation of cells exposed to CA, with this being more effective at 20°C (F1,44=16.82,
p<0.0005 at 6h) than 37°C (F1,44=6.60, p<0.014). Indeed, at 0.1mM CA there was a 70%
reduction of EP-procyclin expression compared to the control line at 6h, this expression
being further reduced over 24h due to reversal of cold-induction at 27°C (Figure 4C;
Supplementary Fig. 7). Matching the response to CA, PAD RNAi also diminished the
response of stumpy cells to citrate at 20°C (Supplementary Fig. 8). A cell-line specific
differentiation-defect unrelated to PAD RNAi was eliminated by transiently-transfecting
pleomorphic cells with the RNAi construct, this recapitulating the differentiation phenotype
(Supplementary Fig. 9). Moreover, the RNAi lines differentiated as well as parental cells in
response to pronase treatment, an alternative differentiation trigger (Supplementary Fig.
10)15. Hence, ablating PAD mRNAs reduced overall differentiation responses to CCA at all
concentrations tested but specifically abrogated the cold-induced CCA-hypersensitivity of
stumpy-forms.
Conclusions
These experiments demonstrate that the PAD proteins act as transducers of the CCA
differentiation signal in Trypanosoma brucei. This conclusion is based on several lines of
evidence: (i) PAD proteins are surface molecules expressed on stumpy-forms but absent in
transmission-incompetent slender-forms (ii) at the single-cell level, PAD protein expression
correlates precisely with the differentiation capacity of bloodstream-form parasites (iii) at
least one PAD protein (PAD2) demonstrates cold-regulated expression and localisation,
consistent with predictions for the reception of the CCA signal in vivo and (iv) depletion of
PAD protein expression in pleomorphic trypanosomes reduces their competence for
differentiation and eliminates CCA-responsiveness at physiologically-relevant
concentrations. In laboratory-adapted monomorphic slender trypanosomes, which do not
express detectable levels of PAD proteins but which can differentiate in response to CCA,
signalling is likely driven through other transporters by the high concentrations of CCA
required for differentiation in these cell lines14. Consistent with this, incubating
monomorphic slender forms, T. brucei AnTat 1.1 90:13 stumpy forms and the PAD RNAi
stumpy forms with 14C citrate revealed a clear correlation between PAD expression and
cell-associated label (Supplementary Fig. 11). All of these characteristics are compatible
with current models for the reception of the signal to differentiation from bloodstream to
procyclic-forms8, with the relay of the CCA signal by PAD proteins providing the first
molecular insight linking environmental-sensing to trypanosome cell-type differentiation.
Notably, this does not exclude an additional or complementary role of proteases in the tsetse
midgut, which can act with CCA to promote robust differentiation22.
The identification of PAD1 as a stumpy-specific surface marker protein also provides two
key advances. Firstly, the precise correlation between PAD1 expression and differentiation-
capacity directly confirms stumpy-forms as the essential transmissible-stage in the
bloodstream, supporting classical observations23 but contrasting with some recent
models24. Secondly, the discovery of PAD1 permits the quantitative modelling of
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trypanosome population dynamics in chronic infections25 and the development of bioassays
to detect stumpy-formation. This has obvious application for monitoring the activity of the
signal for quorum-sensing, SIF, and in high-throughput screens for therapeutic agents that
promote stumpy-formation and hence prevent parasite virulence.
Methods Summary
PAD RNAi constructs
PAD protein sequences from GeneDB were analysed using TMHMM26 and displayed using
TMRPres2D27 to determine the position of the transmembrane helices. The PAD1 reading
frame was amplified from genomic DNA by polymerase chain reaction using 5′-
tttaagctttgatcaatgagcgcacccgtcgacaacgtc-3′ and 5′-
aaactcgagcatatgtcattgcggagcagcctcacgggc-3′ primers, and cloned into the HindIII-XbaI and
XhoI-BamHI cloning sites of pALC1428 to generate the PAD RNAi plasmid.
Parasite growth and transfection
Culturing, transfection, differentiation, and cold-shock assays were performed as
described2,29 on T. brucei AnTat1.1 90-132 and selected using 0.5 μg ml−1 puromycin.
Stumpy-enriched populations were obtained by DEAE-cellulose purification30 of parasites
6-7 days post-infection into cyclophosphamide-treated mice.
PAD-expression analysis
Peptides specific to PAD1 (H2N-CPKEPTRDAREAAPQ-COOH and H2N-
ETCCRREVAE-COOH), PAD2 (H2N-EAEDNQTNAENVC-COOH and H2N-
CNADACLEEKAADSSK-COOH) and the entire array (H2N-VETDVDYIAPQFQET-
CONH2 and H2N-TQQADKLGQDVCTER-COOH) were used to generate antipeptide
antibodies (Eurogentec). Immunofluorescence analysis was performed31 using a Zeiss
Axioscope 2 or Leica SP5 confocal microscope and analysed using Volocity software
(Improvision). Images were processed using Adobe Photoshop CS. Western blotting was
performed by low-voltage SDS-PAGE and wet transfer onto Immobilon-P PVDF
(Millipore) according to the manufacturer's instructions; proteins were detected using the LI-
COR Odyssey system for quantification against a tubulin loading control. Flow cytometry
analysis was performed using the FACS-Calibur flow cytometer (Becton Dickenson)11.
Xenopus oocyte transport assays
PAD genes were cloned into pGHJ and radiolabelled citrate experiments were performed as
described32. Uptake measurements were made over 1h in oocytes (5-days post-injection)
incubated at pH 9 and 27.5°C.
Statistical analysis
Differentiation data were analysed using a general linear model. Residuals did not conform
to a normal distribution and therefore a logarithmic transformation was used. Statistical
analysis was carried out using minitab version 15, with P values of p< 0.05 being considered
statistically significant.
Methods
Trypanosomes
Trypanosoma brucei brucei AnTat1.1 and Trypanosoma brucei brucei EATRO 2340 were
used. Stumpy forms were generated by 5-6 days growth in MF1 mice, treated with
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cyclophosphamide 24h prior to infection. Slender and monomorphic slender parasites were
generated after 3 days growth in rodents.
For pleomorphic transfection, cells from an early-stage parasitaemia (3–4 days, depending
on the infection) were purified from the buffy coat and the cells transfected using an
AMAXA nucleofector protocol (T-cell nucleofection buffer, programme X001). Drug
selection was carried out in cells maintained in HMI-9 media supplemented with 1.1%
methyl cellulose at a concentration of approximately 5 × 106 cell ml−1. Transgenic parasites
were selected using 0.5 μg ml−1 puromycin.
Macroarray analysis
Expression differences between the DiD1 and parental progenitor were carried out by
reverse transcription of 5μg of polyA+ RNA from each cell type, this being labelled using
the GE Healthcare Gene Images non-radioactive labelling system. Macroarrays, a gift from
Professor Elisabetta Ullu, Yale University, USA, comprised 15,000 plasmid clones of 1-2Kb
sheared DNA (~0.8x genome coverage) from Trypanosoma brucei TREU 927/4 cloned into
pUC18 and arrayed in 384 microtitre dishes over 39 plates. Bacterial clones were spotted
onto 22cm2 nylon membranes in a 4×4 array format. After hybridization, signals were
detected by ECL and differential signals, obtained in duplicate, were identified and validated
by northern analysis.
Western analysis of PAD proteins
Cells were resuspended at 3 × 106 cells in 10 μl of Laemmli sample buffer containing β-
mercaptoethanol at room temperature. Genomic DNA was then sheared by sonication and
the sample placed upon ice. 10 μl of protein sample was then resolved on a 10%
polyacrylamide gel at 100V at 4°C for approximately 4 hours using chilled buffers. Gels
were blotted onto PVDF Immobilon-P (Millipore) at 4°C using a wet blotting system
(BioRAD) with chilled buffers. For western blotting, primary antibodies were used at
1:1000 and secondary antibodies were used at 1:5000. Detection after primary antibody
incubation used IRDye 680 Goat Anti-Rabbit IgG or IRDye 800CW Goat Anti-Mouse IgG,
and was analysed via a Li-COR Odyssey Imager.
Immunofluorescence
For methanol fixation to preserve the overall cell shape, cells were spread onto microscope
slides, and air-dried prior to fixation in methanol at −20°C for at least 10 minutes. Cells
were rehydrated in PBS for 10 minutes prior to labelling, this being carried out as for
paraformaldehyde fixed cells. For paraformaldehyde fixation, 2×106 cells were resuspended
in 100μl vPBS (8g/l NaCl; 0.22g/l KCl; 2.27g/l Na2HPO4; 0.41g/l KH2PO4; 15.7g/l
sucrose, 1.8g/l glucose; pH7.4), and then an equal volume of 6% paraformaldehyde added.
After 10 minutes the suspension was diluted to 5ml in vPBS and settled onto poly-L-lysine
coated slides for 20 minutes and then washed with PBS. The cells were then permeabilised
in 0.05% Triton X100 for 10 minutes, blocked in 20 % foetal calf serum (FCS) in vPBS for
45 minutes, and stained with the primary antibody (1:100) in 20 % FCS in vPBS for >1
hour.
Subsequent to washing in excess PBS, the cells were stained with the secondary antibody
(1:500) in 20 % FCS: vPBS for 1 hour, washed in excess PBS 3 × 5 minutes after which the
cellular DNA was stained with a 1 μg ml−1 4′,6-diamidino-2-phenylindole. Cells were
mounted in MOWIOL containing phenylene diamine.
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Flow cytometry
Between 2 – 5 × 106 cells were fixed in 2 % formaldehyde/ 0.05 % glutaraldehyde for a
minimum of 1 hour at 4 °C. Subsequently, the cell suspension was pelleted and resuspended
in 200 μl of EP procyclin antibody (Cedar Lane Laboratories) diluted 1:500 in 2 % BSA in
PBS. Cells were washed twice prior to being stained with the primary antibody, washed
twice and stained with the secondary antibody (1:500). Flow cytometry data were analysed
using FlowJO (Tree Star Inc.) software, with unstained cells, and cells stained with only the
secondary antibody providing negative controls.
Image acquisition equipment and settings
Immunofluorescence microscopy images (Figure 2c) were captured on a Zeiss axioskop 2
(Carl Zeiss microimaging, Inc.) with a Prior Lumen 200 light source using a QImaging
(QImaging, Bucks, UK) Retiga 2000R CCD camera; objectives were either Plan Neofluar
63x (1.25 NA) or Plan Neofluar 100x (1.30 NA). Images were captured via QImage
(QImaging, Bucks, UK) and pseudocoloured using Adobe photoshop CS. Confocal imaging
(Figure 2a; Figure 3c) used a Leica SP5 confocal laser scanning microscope, using x63 oil
immersion objective (N.A.=1.4), with 4.2x zoom. The green channel was imaged using a
488nm argon laser, the red channel was imaged using a 543nm Helium/Neon laser and the
image was acquired at 1024/1024 voxels for x/y resolution with sequential optical sections
of 0.54μm in z-axis increments. The image was optimised by adjusting laser power and
detector sensitivity to minimise bleaching and maintain a digital signal of between 0-255 to
avoid signal loss or saturation. The final image was acquired using Volocity™ Software
(Improvision Ltd, Coventry, UK) Version 4.4.
Acknowledgments
We thank Elisabetta Ullu (Yale University) for the gift of genomic macroarrays, Markus Engstler (University of
Darmstadt, Germany) and Michael Boshart (University of Munich, Germany) for the gift of the AnTat 90:13 line,
and Andre Schneider (University of Bern, Switzerland) for pALC14. We thank Deborah Hall, Pamela Davies and
Dan Levin for technical assistance, Paula MacGregor for statistical analysis and Athina Paterou and Dianne Murray
for Image analysis. This work was supported by a Wellcome Trust project grant and programme grant to KM. SD
was supported by a BBSRC studentship, a Wellcome Trust Programme Grant to KM and by a Journal of Cell
Science Travelling fellowship for a visit to the laboratory of KK. Support was also provided through a Wellcome
Trust strategic award for the Centre for Immunity, Infection and Evolution and a BBSRC REI award for confocal
facilities.
References
1. Fang J, McCutchan TF. Thermoregulation in a parasite's life cycle. Nature. 2002; 418(6899):742.
[PubMed: 12181557]
2. Engstler M, Boshart M. Cold shock and regulation of surface protein trafficking convey
sensitization to inducers of stage differentiation in Trypanosoma brucei. Genes Dev. 2004; 18(22):
2798. [PubMed: 15545633]
3. Lee SH, Stephens JL, Paul KS, Englund PT. Fatty acid synthesis by elongases in trypanosomes.
Cell. 2006; 126(4):691. [PubMed: 16923389]
4. Hao Z, et al. Tsetse immune responses and trypanosome transmission: implications for the
development of tsetse-based strategies to reduce trypanosomiasis. Proc. Natl. Acad. Sci. USA.
2001; 98(22):12648. [PubMed: 11592981]
5. Zilberstein D, Shapira M. The role of pH and temperature in the development of Leishmania
parasites. Ann. Rev. Microbiol. 1994; 48:449. [PubMed: 7826014]
6. Billker O, et al. Identification of xanthurenic acid as the putative inducer of malaria development in
the mosquito. Nature. 1998; 392(6673):289. [PubMed: 9521324]
7. Barrett MP, et al. The trypanosomiases. Lancet. 2003; 362(9394):1469. [PubMed: 14602444]
Dean et al. Page 7
Nature. Author manuscript; available in PMC 2009 November 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
8. Fenn K, Matthews KR. The cell biology of Trypanosoma brucei differentiation. Curr. Op.
Microbiol. 2007; 10(6):539.
9. Szoor B, et al. Protein tyrosine phosphatase TbPTP1: a molecular switch controlling life cycle
differentiation in trypanosomes. J. Cell Biol. 2006; 175(2):293. [PubMed: 17043136]
10. Tasker M, et al. A novel selection regime for differentiation defects demonstrates an essential role
for the stumpy form in the life cycle of the African trypanosome. Mol. Biol. Cell. 2000; 11(5):
1905. [PubMed: 10793160]
11. Vassella E, Reuner B, Yutzy B, Boshart M. Differentiation of African trypanosomes is controlled
by a density sensing mechanism which signals cell cycle arrest via the cAMP pathway. J Cell Sci.
1997; 110(Pt 21):2661. [PubMed: 9427384]
12. Bruce D, et al. The morphology of the trypanosome causing disease in man in Nyasaland. Proc.
Roy. Soc. B. 1912; 85:423.
13. Turner CM, Barry JD, Vickerman K. Loss of variable antigen during transformation of
Trypanosoma brucei rhodesiense from bloodstream to procyclic forms in the tsetse fly. Parasitol.
Res. 1988; 74(6):507. [PubMed: 3194363]
14. Czichos J, Nonnengaesser C, Overath P. Trypanosoma brucei: cis-aconitate and temperature
reduction as triggers of synchronous transformation of bloodstream to procyclic trypomastigotes in
vitro. Exp. Parasitol. 1986; 62(2):283. [PubMed: 3743718]
15. Hunt M, Brun R, Kohler P. Studies on compounds promoting the in vitro transformation of
Trypanosoma brucei from bloodstream to procyclic forms. Parasitol. Res. 1994; 80(7):600.
[PubMed: 7855126]
16. Jacobs SL, Lee ND. Determination of Citric Acid in Serum and Urine Using Br82. J. Nucl. Med.
1964; 5:297. [PubMed: 14168702]
17. Sherwin T, Gull K. The cell division cycle of Trypanosoma brucei brucei: timing of event markers
and cytoskeletal modulations. Phil. Trans. Roy. Soc. London. 1989; 323(1218):573. [PubMed:
2568647]
18. Shapiro SZ, Naessen J, Liesegang B, et al. Analysis by flow cytometry of DNA synthesis during
the life cycle of African trypanosomes. Acta tropica. 1984; 41(4):313. [PubMed: 6152113]
19. Matthews KR, Gull K. Evidence for an interplay between cell cycle progression and the initiation
of differentiation between life cycle forms of African trypanosomes. J. Cell Biol. 1994; 125(5):
1147. [PubMed: 8195296]
20. Kamsteeg EJ, et al. MAL decreases the internalization of the aquaporin-2 water channel. Proc.
Natl. Acad. Sci. USA. 2007; 104(42):16696. [PubMed: 17940053]
21. Kirk P, et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates
their cell surface expression. EMBO J. 2000; 19(15):3896. [PubMed: 10921872]
22. Sbicego S, et al. The use of transgenic Trypanosoma brucei to identify compounds inducing the
differentiation of bloodstream forms to procyclic forms. Mol. Biochem. Parasitol. 1999; 104:311.
[PubMed: 10593184]
23. Robertson M. Notes on the polymorphism of Trypanosoma gambiense in the blood and its relation
to the exogenous cycvle in Glossina palpalis. Proc. Roy. Soc. B. 1912; 85:241.
24. Bass KE, Wang CC. The in vitro differentiation of pleomorphic Trypanosoma brucei from
bloodstream into procyclic form requires neither intermediary nor short-stumpy stage. Mol.
Biochem. Parasitol. 1991; 44(2):261. [PubMed: 2052026]
25. Lythgoe KA, Morrison LJ, Read AF, Barry JD. Parasite-intrinsic factors can explain ordered
progression of trypanosome antigenic variation. Proc. Natl. Acad. Sci. USA. 2007; 104(19):8095.
[PubMed: 17463092]
26. Tusnady GE, Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics
(Oxford, England). 2001; 17(9):849.
27. Spyropoulos IC, Liakopoulos TD, Bagos PG, Hamodrakas SJ. TMRPres2D: high quality visual
representation of transmembrane protein models. Bioinformatics (Oxford, England). 2004; 20(17):
3258.
28. Pusnik M, et al. Pentatricopeptide repeat proteins in Trypanosoma brucei function in mitochondrial
ribosomes. Mol. Cell. Biol. 2007; 27(19):6876. [PubMed: 17646387]
Dean et al. Page 8
Nature. Author manuscript; available in PMC 2009 November 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
29. McCulloch R, et al. Transformation of monomorphic and pleomorphic Trypanosoma brucei.
Methods in molecular biology (Clifton, N.J. 2004; 262:53.
30. Lanham SM. Separation of trypanosomes from the blood of infected rats and mice by anion-
exchangers. Nature. 1968; 218(5148):1273. [PubMed: 5656665]
31. Field MC, et al. New approaches to the microscopic imaging of Trypanosoma brucei. Microsc
Microanal. 2004; 10(5):621. [PubMed: 15525435]
32. Saliba KJ, et al. Sodium-dependent uptake of inorganic phosphate by the intracellular malaria
parasite. Nature. 2006; 443(7111):582. [PubMed: 17006451]
Dean et al. Page 9
Nature. Author manuscript; available in PMC 2009 November 15.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 1. Identification and characteristics of PAD proteins
(a) Expression of PAD-mRNAs in DiD-1, parental slender-forms (“Sl”), stumpy-forms
(“St”) and procyclic-forms (“Pcf”). rRNAs show loading.
(b) Predicted transmembrane domains in PAD1.
(a) [14C]citrate uptake into Xenopus oocytes microinjected with 20 ng cRNA encoding
PAD1 or PAD2, or non-injected. The data (from 8-10 oocytes, shown ± s.e.m.) are
representative of ten experiments in which oocytes expressing PAD1 exhibited 1.4-3.7-
fold increase in [14C]citrate uptake and oocytes expressing PAD2 exhibited 1.6-5.4-fold
increase relative to non-injected controls.
(b) Expression of PAD proteins in slender-, stumpy- and procyclic-forms normalised to
α-tubulin. The PAD2-antibody cross-reacts weakly with the 60kDal VSG in slender-
forms.
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Figure 2. PAD1 identifies stumpy forms
(a) PAD1-expression on methanol-fixed trypanosomes. The slender-cell (‘sl’; identified
by having two kinetoplasts, arrowed in the DAPI panel) is PAD1-negative, the stumpy-
cell (‘St’) is PAD1-positive. A confocal image of a paraformaldehyde-fixed stumpy-
form is also shown (right); peripheral PAD1-labelling (green) is arrowed; nucleus, ‘n’,
and kinetoplast, ‘k’, (both stained blue).
(b) Quantitation of PAD1 expression on different cell-cycle stages.
(c) PAD1-positive cells are those competent to differentiate. Slender and stumpy-forms
were methanol-fixed 6hr through differentiation. A slender-morphology PAD1-
negative, EP-Procyclin-negative cell is arrowed, other cells are PAD1-positive (red),
EP-procyclin-positive (green). Phase-contrast and DAPI images are also shown.
(d) Quantitation of the cells expressing PAD1 and/or EP-procyclin. n=500.
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Figure 3. PAD2 is cold-inducible
(a) PAD protein expression at 37°C or 20°C in stumpy-forms of T. brucei EATRO 2340
or T. brucei AnTat1.1. Samples were stained for all PAD proteins (“Array”), PAD1 or
PAD2. α-tubulin controlled for loading.
(b) Confocal immunofluorescence-images of paraformaldehyde-fixed stumpy-forms
incubated at 37°C or 20°C and co-labelled for α-tubulin (red), PAD2 (green) and DAPI
(blue). At 37°C, PAD2 predominantly localised to the flagellar pocket (f.p.; arrowed); at
20°C PAD2 located at the cell surface.
(c) Quantitation of the PAD2 location at 37°C or 20°C.
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Figure 4. RNAi against all PAD genes reduces differentiation
(a) PAD-array expression in parental or PAD-RNAi lines (±doxycycline, D+, D) after
16h at 20°C. Tubulin, loading control.
(b) EP-procyclin in Parental (‘P’) and PAD-RNAi stumpy-forms grown ±doxycycline
(D+, D−) after 16h at 20°C, then incubated at 27°C with a CA titration. Means (±s.e.m.)
of three experiments are shown, as is the % reduction in EP-procyclin in the PAD-
RNAi cells compared with parental cells.
(c) Flow-cytometry of EP-procyclin expression in PAD-RNAi or parental cells
incubated with 0.1mM or 1mM CA. Cold-induced hypersensitivity to CA is ablated in
the PAD-RNAi line; at ≥1mM CA both populations differentiate, although this is
reduced in the RNAi line. Full flow cytometry data are available in Supplementary Fig.
7.
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